A note on lung cancer in the COVID-19 era
- PMID: 33682217
- PMCID: PMC8250476
- DOI: 10.1111/resp.14035
A note on lung cancer in the COVID-19 era
Abstract
See related
Figures

Comment in
-
Reply.Respirology. 2021 May;26(5):511-512. doi: 10.1111/resp.14033. Epub 2021 Mar 7. Respirology. 2021. PMID: 33682253 No abstract available.
Comment on
-
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12. Lancet Oncol. 2020. PMID: 32539942 Free PMC article.
-
Delayed access to lung cancer screening and treatment during the COVID-19 pandemic: Are we headed for a lung cancer pandemic?Respirology. 2021 Feb;26(2):145-146. doi: 10.1111/resp.13996. Epub 2020 Dec 15. Respirology. 2021. PMID: 33325075 No abstract available.
References
-
- Leong TL. Delayed access to lung cancer screening and treatment during the COVID‐19 pandemic: are we headed for a lung cancer pandemic? Respirology 2021; 26: 145–6. - PubMed
-
- Grange M, Peake M, Rintoul R. Assessing the impact of COVID‐19 on lung cancer services. [Accessed 23 Jan 2021.] Available from URL: https://www.uklcc.org.uk/assessing-the-impact-of-covid-19-on-lung-cancer...
-
- Evison M, Grundy S, Bailey S, Booton R, Shah R, Bayman N, Blackhall F, Lindsay C, Toy L, Hatton M et al. Cancer Clinical Expert Group. Differentiate between the C's. [Accessed 21 Jan 2021.] Available from URL: https://www.roycastle.org/for‐healthcare‐professionals/clinical‐expert‐g...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical